Cell-Permeable Peptides Containing Cycloalanine Residues.

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Drug Discovery

Background:

• N-methylation is a common strategy to improve peptide stability and cell permeability.
• Existing methods for peptide modification can involve complex and challenging chemical coupling steps.
• Developing novel, efficient peptide modification techniques is crucial for therapeutic applications.

Purpose of the Study:

• To introduce cycloalanine (CyAla) as an efficient alternative to N-methylation for peptide modification.
• To develop a method for incorporating CyAla into peptides that circumvents difficult coupling procedures.
• To create a cell-permeable peptide derivative with potential therapeutic applications, exemplified by an HIV Rev protein-binding peptide.

Main Methods:

• Peptide synthesis incorporating a cycloalanine residue.
• Chemical characterization of the modified peptides.
• Assessment of serum stability and cell permeability of the resulting compounds.
• Evaluation of the derivative's binding affinity to the HIV Rev protein.

Main Results:

• Successfully incorporated cycloalanine into peptides using a straightforward method.
• Demonstrated enhanced serum stability and cell permeability of CyAla-modified peptides compared to traditional methods.
• Developed a cell-permeable derivative of a high-affinity HIV Rev protein-binding peptide.
• The new method avoids the challenging coupling steps often associated with peptide modifications.

Conclusions:

• Cycloalanine incorporation offers an efficient and practical alternative to N-methylation for enhancing peptide properties.
• This strategy significantly improves serum stability and cell permeability, broadening the potential of peptide-based therapeutics.
• The developed methodology holds promise for creating effective cell-permeable peptide drugs, particularly for challenging targets like the HIV Rev protein.